Sinofn Health
Sinofn Health
Scientific Excellence & Global Supply Chain Solutions for Next-Gen Nutraceuticals
In the rapidly evolving nutraceutical landscape, **OEM Private Label Gummy Vitamins** have emerged as the dominant delivery system, favored by consumers for their palatability, convenience, and perceived health benefits. Unlike traditional tablets or hard capsules, gummies bridge the gap between "medicinal consumption" and "pleasurable snacking."
The global contract manufacturing sector is shifting toward advanced delivery systems. As an industry leader, SINOFN observes a distinct trend: consumers are moving away from synthetic fillers and toward clean-label, plant-based pectin gummies. Our research indicates that brands partnering with science-driven manufacturers gain an information gain advantage by leveraging superior bioavailability formulations, such as encapsulated lipids and heat-stable probiotics within the gummy matrix.
The future of gummy manufacturing lies in "Functional Precision." We are moving beyond simple vitamin supplementation into targeted health outcomes—nootropics for focus, adaptogens for stress, and postbiotics for gut health. SINOFN’s proprietary technology integrates advanced encapsulation to mask bitter bioactive compounds, ensuring a premium sensory experience while maintaining strict GMP and FSSC 22000 compliance.
SINOFN Health Co., Ltd. serves as the specialized OEM division of the SINOFN Group. Established in 2012, our organization is rooted in rigorous scientific inquiry, supported by partnerships with the Chinese Academy of Sciences. We don't just manufacture; we engineer nutritional solutions.
Our founder, Mrs. GuoHong Liu, transitioned from clinical practice to industrial innovation with a singular mission: to democratize access to high-quality specialized nutrition, specifically within the underserved PKU (Phenylketonuria) sector. This legacy of "profit with purpose" defines our manufacturing ethics today.
Quality in supplement manufacturing is a derivative of human expertise. Our R&D team is spearheaded by Dr. Zhang Ying (CAS Associate Researcher) and Dr. Tan Shengjie (Peking University Medical Doctor), ensuring that every formulation is evidence-based. With our EU-based technical consultant, Hans van Dijk, we ensure that our manufacturing standards meet global, and specifically European, regulatory requirements.
Medical Innovation Director, Ph.D. Peking University
R&D Lead, CAS Postdoc
Formulation Director, Senior Scientist (Netherlands)
Focusing on metabolic disorder formulations and bioavailability optimization.
A: Yes. We operate dedicated pilot-scale production lines specifically for prototyping. We collaborate with clients to perform bioavailability studies and shelf-life testing before full-scale manufacturing.
A: Absolutely. Our scalable manufacturing processes are designed to handle flexible order volumes, supporting emerging brands in their incubation phase and large-scale enterprises with high-volume requirements.
A: Headquartered in Shanghai, we serve global markets. Our facility certifications (ISO 22000, HACCP, FSSC 22000, HALAL) ensure that our products meet the regulatory standards of major markets including the EU, North America, and Southeast Asia.
